Central histaminergic system interactions and cognition

  • Patrizio Blandina
  • Maria Beatrice Passani
Part of the Experientia Supplementum book series (EXS, volume 98)


Histamine Receptor Contextual Fear Conditioning Nucleus Basalis Magnocellularis Histaminergic Neuron Histaminergic System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kwiatkowski H (1943) Histamine in nervous tissue. J Physiol 102: 32–41PubMedGoogle Scholar
  2. 2.
    Green JP (1964) Histamine and the nervous system. Fed Proc 23: 1095–1102PubMedGoogle Scholar
  3. 3.
    Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4: 121–130PubMedCrossRefGoogle Scholar
  4. 4.
    Green JP (1987) Histamine receptors, In: HY Meltzer et al. (eds): Psychopharmacology: The third generation of progress. Raven, New York, 273–279Google Scholar
  5. 5.
    Wada H, Inagaki N, Yamatodani A, Watanabe T (1991) Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 14: 415–418PubMedCrossRefGoogle Scholar
  6. 6.
    Panula P, Yang HY, Costa E (1984) Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci 81: 25722576CrossRefGoogle Scholar
  7. 7.
    Watanabe T, Taguchi Y, Hayashi H, Tanaka J, Shiosaka S, Tohyama M, Kubota H, Terano Y, Wada H (1983) Evidence for the presence of a histaminergic neuron system in the rat brain:an immunohistochemical analysis. Neurosci Lett 39: 249254CrossRefGoogle Scholar
  8. 8.
    Ericson H, Watanabe T, Köhler C (1987) Morphological analysis of the tuberomammillary nucleus of the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol 263: 1–24PubMedCrossRefGoogle Scholar
  9. 9.
    Green JP, Prell GD, Khandelwal JK, Blandina P (1987) Aspects of histamine metabolism. Agents Actions 22: 1–15PubMedCrossRefGoogle Scholar
  10. 10.
    Kollonitsch J, Patchett AA, Marburg S, Maycock AL, Perkins LM, Doldouras GA, Duggan DE, Aster SD (1978) Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature 274: 906–908PubMedCrossRefGoogle Scholar
  11. 11.
    Inagaki N, Toda K, Taniuchi I, Panula P, Yamatodani A, Tohyama M, Watanabe T, Wada H (1990) An analysis of histaminergic efferents of the tuberomammillary nucleus to the medial preoptic area and inferior colliculus of the rat. Exp Brain Res 80: 374–380PubMedCrossRefGoogle Scholar
  12. 12.
    Inagaki N, Yamatodani A, Shinoda K, Shiotani Y, Tohyama M, Watanabe T, Wada H (1987) The histaminergic innervation of the mesencephalic nucleus of trigeminal nerve in the rat brain: A light and electron microscopic study. Brain Res 418: 388–391PubMedCrossRefGoogle Scholar
  13. 13.
    Tohyama M, Tamiya R, Inagaki N, Tagaki H (1991) Morphology of histaminergic neurons with histidine decarboxylase as a marker. In: Watanabe T, Wada H (eds): Histaminergic neurons: morphology and function. CRC Press, Boca Roton, 107–126Google Scholar
  14. 14.
    Takagi H, Morishima Y, Matsuyama T, Hayashi H, Watanabe T, Wada H (1986) Histaminergic axons in the neostriatum and cerebral cortex of the rat: A correlated light and electron microscope immunocytochemical study using histidine decarboxylase as a marker. Brain Res 364: 114–123PubMedCrossRefGoogle Scholar
  15. 15.
    Michelsen K, Panula P (2002) Subcellular distribution of histamine in mouse brain neurons. Inflamm Res 51,Suppl 1: S46–48PubMedGoogle Scholar
  16. 16.
    Inagaki N, Fukui H, Taguchi Y, Wang N, Yamatodani A, Wada H (1989) Characterization of histamine H1-receptors on astrocytes in primary culture: [3H]mepyramine binding studies. Eur J Pharmacol 173: 43–51PubMedCrossRefGoogle Scholar
  17. 17.
    Carman-Krzan M, Lipnik-Stangelj M (2000) Molecular properties of central and peripheral histamine H1 and H2 receptors. Pflugers Arch 439: 131–132CrossRefGoogle Scholar
  18. 18.
    Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL (1997) International union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49: 253–278PubMedGoogle Scholar
  19. 19.
    Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S (2000) Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275: 36781–36786PubMedCrossRefGoogle Scholar
  20. 20.
    Zhu Y, Michalovich A, Wu H-L, Tang K, Dytko GM (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59: 434–441PubMedGoogle Scholar
  21. 21.
    Liu C, Ma X-J, Wilson S, Hofstra C, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg T (2001) Cloning and pharmacological characterization of of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59: 420–426PubMedGoogle Scholar
  22. 22.
    Liu C, Wilson S, Kuei C, Lovenberg T (2001) Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299: 121–130PubMedGoogle Scholar
  23. 23.
    Smit M, Leurs R, Alewijnse A, Blauw J, Amongen G, Vandevrede T, Roovers E, Timmerman H (1996) Inverse agonism of histamine H2 antagonists accounts for upregulation of spontaneously active histamine H2 receptors. Proc Nat Acad Sci 93: 6802–6807PubMedCrossRefGoogle Scholar
  24. 24.
    Bakker R, Wieland K, Timmerman H, Leurs R (2000) Constitutive activity of the H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur J Pharmacol 387: R5–R7PubMedCrossRefGoogle Scholar
  25. 25.
    Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz J-C, Arrang J-M (2000) High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408: 860–864PubMedCrossRefGoogle Scholar
  26. 26.
    Wieland K, Bongers G, Yamamoto Y, Hashimoto T, Yamatodani A, Menge W, Timmerman H, Lovenberg T, Leurs R (2001) Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists. J Pharmacol Exp Ther 299: 908–914PubMedGoogle Scholar
  27. 27.
    Rouleau A, Ligneau X, Tardive-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM (2002) Histamine H3 receptor mediated [35S] GTP gamma[s] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. Br J Pharmacol 135: 383–392PubMedCrossRefGoogle Scholar
  28. 28.
    Crochet S, Sakai K (1999) Effects of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur J Neurosci 11:3738–3752PubMedCrossRefGoogle Scholar
  29. 29.
    Cahill L, McGaugh J (1995) A novel demonstration of enhanced memory associated with emotional arousal. Conscious Cogn 4: 410–421PubMedCrossRefGoogle Scholar
  30. 30.
    Parmentier R, Ohtsu H, Djebarra-Hannas Z, Valtx J-L, Watanabe T, Lin J-S (2002) Anatomical, physiological and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22: 7695–7711PubMedGoogle Scholar
  31. 31.
    Nishino S, Fujiki N, Ripley B, Sakurai E, Kato M, Watanabe T, Mignot E, Yanai K (2001) Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 313: 125–128PubMedCrossRefGoogle Scholar
  32. 32.
    Sakai K, Mansari ME, Lin J, Zhang J, Mercier GV (1990) The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. In: Mancia M (ed): The diencephalon and sleep. Raven Press, New York, 171–198Google Scholar
  33. 33.
    Lin JS (2000) Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev 4: 471–503CrossRefGoogle Scholar
  34. 34.
    Passani MB, Lin J-S, Hancock A, Crochet S, Blandina P (2004) The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25: 618–625PubMedCrossRefGoogle Scholar
  35. 35.
    Cecchi M, Passani MB, Bacciottini L, Mannaioni PF, Blandina P (2001) Cortical Acetylcholine release elicited by stimulation of histamine H1 receptors in the nucleus basalis magnocellularis: a dual probe microdialysis study in the freely moving rat. Eur J Neurosci 13: 68–78PubMedCrossRefGoogle Scholar
  36. 36.
    Lin J, Sakai K, Jouvet M (1994) Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat. Eur J Neurosci 6: 618–625PubMedCrossRefGoogle Scholar
  37. 37.
    Lin JS, Hou Y, Sakai K, Jouvet M (1996) Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16: 1523–1537PubMedGoogle Scholar
  38. 38.
    Mignot E, Taheri S, Nishino S (2002) Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 5Suppl: 1071–1075PubMedCrossRefGoogle Scholar
  39. 39.
    Huang Z-L, Qu W-M, Li W-D, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O (2001) Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci 98: 9965–9970PubMedCrossRefGoogle Scholar
  40. 40.
    Eriksson K, Sergeeva O, Brown R, Haas H (2001) Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21: 9273–9279PubMedGoogle Scholar
  41. 41.
    Passani MB, Bacciottini L, Mannaioni PF, Blandina P (2000) Central histaminergic system and cognitive processes. Neurosci Biobehav Rev 24: 107–114PubMedCrossRefGoogle Scholar
  42. 42.
    Passani M, Blandina P (2004) The neuronal histaminergic system in cognition. Curr Med Chem 4: 17–26Google Scholar
  43. 43.
    deAlmeida M, Izquierdo I (1986) Memory facilitation by histamine. Arch Int Pharmacodyn Ther 283: 193–198Google Scholar
  44. 44.
    Kamei C (1990) Influence of certain H1-blockers on the step-through active avoidance response in rats. Psychopharmacology 102: 312–318PubMedCrossRefGoogle Scholar
  45. 45.
    Huston JP, Wagner U, Hasenöhrl RU (1997) The tuberomammilary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 83: 97–105PubMedCrossRefGoogle Scholar
  46. 46.
    Klapdor K, Hasenöhrl RU, Huston JP (1994) Facilitation of learning in adult and aged rats following bilateral lesions of the tuberomammilary nucleus region. Behav Brain Res 61: 113–116PubMedCrossRefGoogle Scholar
  47. 47.
    Frisch C, Hasenöhrl RU, Haas HL, Weiler HT, Steinbusch HWM, Huston J (1998) Facilitation of learning after lesions of the tuberomammillary nucleus region in adult and aged rats. Exp Brain Res 118: 447–456PubMedCrossRefGoogle Scholar
  48. 48.
    Frisch C, Hasenöhrl RU, Huston JP (1999) Memory improvement by post-trial injection of lidocaine into the tuberomammilary nucleus, the source of neuronal histamine. Neurbiol Learning and Memory 72: 69–77CrossRefGoogle Scholar
  49. 49.
    Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Prog Neurobiol 63: 637–672PubMedCrossRefGoogle Scholar
  50. 50.
    Blandina P, Efoudebe M, Cenni G, Mannaioni PF, Passani MB (2004) Acetylcholine, histamine and cognition: two sides of the same coin. Learn Mem 11: 1–8PubMedCrossRefGoogle Scholar
  51. 51.
    Witkin JM, Nelson DL (2004) Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of central nervous system. Pharmacol Ther 103: 1–20PubMedCrossRefGoogle Scholar
  52. 52.
    Hancock AH, Fox GB (2004) Perspective on cognitive domains, H3 receptor ligands and neurological disease. Expert Opin Investig Drug 13: 1237–1248CrossRefGoogle Scholar
  53. 53.
    Fox GB, Pan JB, Esbenshade TA, Bennani YL, Black LA, Faghih R, Hancock AA, Decker MW (2002) Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup. Behav Brain Res 131: 151–161PubMedCrossRefGoogle Scholar
  54. 54.
    Fox GB, Pan JB, Radek RJ, Lewis AM, Bitner RS, Esbenshade TA, Faghih R, Bennani YL, Williams M, Yao BB et al. (2003) Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization. J Pharmacol Exp Ther 305: 897–908PubMedCrossRefGoogle Scholar
  55. 55.
    Prast H, Argyriou A, Philippu A (1996) Histaminergic neurons facilitate social memory in rats. Brain Res 734: 316–318PubMedCrossRefGoogle Scholar
  56. 56.
    Ligneau X, Lin J-S, Vanni-Mercer G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz JC (1998) Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 287: 658–666PubMedGoogle Scholar
  57. 57.
    Meguro K-I, Yanai K, Sakai N, Sakurai E, Maeyama K, Sasaki H, Watanabe T (1995) Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol Biochem Behav 50: 321–325PubMedCrossRefGoogle Scholar
  58. 58.
    Giovannini MG, Bartolini L, Bacciottini L, Greco L, Blandina P (1999) Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Behav Brain Res 104: 147–155PubMedCrossRefGoogle Scholar
  59. 59.
    Onodera K, Miyazaki S, Imaizumi M, Stark H, Schunack W (1998) Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice. Naunyn-Schmiedeberg’s Arch Pharmacol 357: 508–513CrossRefGoogle Scholar
  60. 60.
    Huang YW, Hua WW, Chen Z, Zhang L-S, Shen H-Q, Timmerman H, Leurs R, Yanai K (2004) Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav Brain Res 151: 287–293PubMedCrossRefGoogle Scholar
  61. 61.
    Stark H (2003) Recent advances in histamine H3/H4 receptor ligands. Expert Opin Ther Patents 13: 851–865CrossRefGoogle Scholar
  62. 62.
    Bongers G, Leurs R, Robertson J, Raber J (2004) Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe-/-mice. Neuropsychopharmacology 29:441–449PubMedCrossRefGoogle Scholar
  63. 63.
    Lovenberg TW, Roland BL, Wilson SJ, Jiang A, Pyati J, Huvar A, Jackson MR, Erlander MG (1999) Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55: 1101–1107PubMedGoogle Scholar
  64. 64.
    Clark EA, Hill SJ (1996) Sensitivity of histamine H3 receptor agonist stimulated [35S]GTP-gamma[S] binding to pertussis toxin. Eur J Pharmacol 296: 223–225PubMedCrossRefGoogle Scholar
  65. 65.
    Hill SJ, Straw RM (1988) Alpha2-Adrenoceptor-mediated inhibition of histamine release from rat cerebral cortical slices. Br J Pharmacol: 95: 1213–1219PubMedGoogle Scholar
  66. 66.
    Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit M, Timmerman H, Panula P, Leurs R (2001) Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1–8PubMedGoogle Scholar
  67. 67.
    Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptors. Nature 302: 832–837PubMedCrossRefGoogle Scholar
  68. 68.
    Arrang JM, Garbarg M, Lancelot JC, Lecont JM, Pollard H, Robba M, Schunack W, Schwartz JC (1987) Highly-potent and selective ligands for histamine-H3 receptors. Nature 327: 117–123PubMedCrossRefGoogle Scholar
  69. 69.
    Itoh Y, Oishi R, Nishibori M, Saeki K (1991) Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis. J Neurochem 56: 769–774PubMedCrossRefGoogle Scholar
  70. 70.
    Mochizuki T, Yamatodani A, Okakura K, Takemura M, Inagaki N, Wada H(1991) In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis. Naunyn-Schmiedeberg’s Arch Pharmacol 343: 190–195CrossRefGoogle Scholar
  71. 71.
    Itoh Y, Oishi R, Adachi N, Saeki K (1992) A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization: its application to biological specimens. J Neurochem 58: 884–889PubMedCrossRefGoogle Scholar
  72. 72.
    Prast H, Fisher HP, Prast M, Philippu A (1994) In vivo modulation of histamine release by autoreceptors and muscarinic acetylcholine receptors in the rat anterior hypothalamus. Naunyn-Schmiedeberg’s Arch Pharmacol 350: 599–604Google Scholar
  73. 73.
    Arrang JM, Garbarg M, Schwartz J (1987) Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience 23: 149–157PubMedCrossRefGoogle Scholar
  74. 74.
    Garbarg M, TrungTuong MD, Gros C, Schwartz JC (1989) Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. Eur J Pharmacol 164: 1–11PubMedCrossRefGoogle Scholar
  75. 75.
    Oishi R, Itoh Y, Nishibori M, Saeki K (1989) Effects of histamine H3-agonist (R)-a-methylhistamine and the antagonist thioperamide on histamine metabolism in the mouse and rat brain. J Neurochem 52: 1388–1392PubMedCrossRefGoogle Scholar
  76. 76.
    Cumming P, Shaw C, Vincent SR (1991) High affinity histamine binding site is the H3receptor: characterization and autoradiographic localization in rat brain. Synapse 8: 144–151PubMedCrossRefGoogle Scholar
  77. 77.
    Pollard H, Moreau J, Arrang JM, Schwartz J-C (1993) A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience 52: 169–189PubMedCrossRefGoogle Scholar
  78. 78.
    Martinez-Mir MI, Pollard H, Arrang JM, Raut M, Traiffort E, Schwartz JC, Palacios J M (1990) Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non human primates. Brain Res 526: 322–327PubMedCrossRefGoogle Scholar
  79. 79.
    Clapham J, Kilpatrick GJ (1992) Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br J Pharmacol 107: 919–923PubMedGoogle Scholar
  80. 80.
    Blandina P, Giorgetti M, Bartolini L, Cecchi M, Timmerman H, Leurs R, Pepeu G, Giovannini MG (1996) Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol 119: 1656–1664PubMedGoogle Scholar
  81. 81.
    Schlicker E, Fink K, Detzner M, Göthert M (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm 93: 1–10CrossRefGoogle Scholar
  82. 82.
    Schlicker E, Fink K, Hinterhaner M, Göthert M (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn-Schmiedeberg’s Arch Pharmacol 340: 633–638CrossRefGoogle Scholar
  83. 83.
    Schlicker E, Betz R, Göthert M (1988) Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg’s Arch Pharmacol 337: 588–590Google Scholar
  84. 84.
    Threlfell S, Cragg SJ, Kallo I, Turi GF, Coen CW, Greenfield SA (2004) Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J Neurosci 24: 8704–8710PubMedCrossRefGoogle Scholar
  85. 85.
    Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7: 151–168PubMedCrossRefGoogle Scholar
  86. 86.
    Buccafusco JJ, Terry Jr AV (2000) Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. J Pharmacol Exp Ther 295: 438–446PubMedGoogle Scholar
  87. 87.
    Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985) Transmitter deficits in Alzheimer’s disease. Neurochem Int 7: 545–563CrossRefGoogle Scholar
  88. 88.
    Schneider C, Risser D, Kirchner L, Kitzmuller E, Cairns N, Prast H, Singewald N, Lubec G (1997) Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease. Neurosci Lett 222: 183–186PubMedCrossRefGoogle Scholar
  89. 89.
    Panula P, Rinnie J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, Relja M (1997) Neuronal histamine deficit in Alzheimer’s disease. Neuroscience 82: 993–997CrossRefGoogle Scholar
  90. 90.
    Birthelmer A, Stemmelin J, Jackisch R, Cassel J-C (2003) Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments. Brain Res Bull 60: 283–296PubMedCrossRefGoogle Scholar
  91. 91.
    Stemmelin J, Lazarus C, Cassel S, Kelche C, Cassel J-C (2000) Immunohistochemical and neurochemical correlates of learning deficits in aged rats. Neuroscience 96: 275–289PubMedCrossRefGoogle Scholar
  92. 92.
    Mesulam MM, Mufson EJ, Wainer BH, Levey AI (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1–Ch6). Neuroscience 10: 1185–1201PubMedCrossRefGoogle Scholar
  93. 93.
    Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula G, Mesulam MM (1994) Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci 14: 1271–1289PubMedGoogle Scholar
  94. 94.
    Arrang JM, Drutel G, Schwartz JC (1995) Characterization of histamine H3 receptors regulating acetylcholine release in rat enthorinal cortex. Br J Pharmacol 114: 1518–1522PubMedGoogle Scholar
  95. 95.
    Goldman-Rakic PS (1987) Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Plum F (ed): Handbook of physiology, Vol. 5 American Physiol Soc, Bethesda, Maryland, 373–417Google Scholar
  96. 96.
    Giorgetti M, Bacciottini L, Bianchi L, Giovannini MG, Cecchi M, Blandina P (1997) GABAergic mechanism in histamine H3 receptor inhibition of K+-evoked release of acetylcholine from rat cortex in vivo. Inflamm Res 46: S3–S4CrossRefGoogle Scholar
  97. 97.
    Freund TF, Meskenaite V (1992) g-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex. Proc Natl Acad Sci 89: 738–742PubMedCrossRefGoogle Scholar
  98. 98.
    Khateb A, Fort P, Pegna A, Jones BE, Mühlertaler M (1995) Cholinergic nucleus basalis neurons are excited by histamine in vitro. Neuroscience 69: 495–506PubMedCrossRefGoogle Scholar
  99. 99.
    Orsetti M, Ferretti C, Gamalero R, Ghi P (2002) Histamine H3-receptor blockade in the rat nucleus basalis magnocellularis improves place recognition memory. Psychopharmacology 159: 133–137PubMedCrossRefGoogle Scholar
  100. 100.
    Malmberg-Aiello P, Ipponi A, Blandina P, Bartolini L, Schunack W (2003) Pro-cognitive effect of a selective H1 receptor agonist, 2-(3-trifluoromethylphenyl)histamine, in the rat object recognition test. Inflam Res 52: S33–S34CrossRefGoogle Scholar
  101. 101.
    Okamura N, Yanai K, Higuchi M, Sakai J, Iwata R, Ido T, Sasaki H, Watanabe T, Itoh M (2000) Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br J Pharmacol 129: 115–123PubMedCrossRefGoogle Scholar
  102. 102.
    Whitehouse PJ, Price DL, Strubble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia; loss of neurons in the basal forebrain. Science 215: 1237–1239PubMedCrossRefGoogle Scholar
  103. 103.
    Aston-Jones G, Rogers J, Shaver RD, Dinan TG, Moss DE (1985) Age-impaired impulse flow from nucleus basalis to cortex. Nature 318: 462–464PubMedCrossRefGoogle Scholar
  104. 104.
    Higuchi M, Yanai K, Okamura N, Meguro H, Arai H, Itoh M, Iwata R, Ido T, Watanabe T, Sasaki H (2000) Histamine H1 receptors in patients with Alzheimer’s disease assessed by positron emission tomography. Neuroscience 99: 721–729PubMedCrossRefGoogle Scholar
  105. 105.
    Gritti I, Mainville L, Mancia M, Jones BE (1997) GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat. J Comp Neurol 383: 163–177PubMedCrossRefGoogle Scholar
  106. 106.
    Giorgetti M, Bacciottini L, Giovannini MG, Colivicchi MA, Goldfarb J, Blandina P (2000) Local GABAergic inhibitory tone of acetylcholine release from the cortex of freely moving rats. Eur J Neurosci 12: 1941–1948PubMedCrossRefGoogle Scholar
  107. 107.
    Davis M (1992) The role of the amygdala in fear and anxiety. Ann Rev Neurosci 15: 353–375PubMedCrossRefGoogle Scholar
  108. 108.
    LeDoux JE (2000) Emotion circuits in the brain. Annu Rev Neurosci 23: 155–184PubMedCrossRefGoogle Scholar
  109. 109.
    Dalmaz C, Introini-Collison IB, McGaugh JL (1993) Noradrenergic and cholinergic interactions in the amygdala and the modulation of memory storage. Behav Brain Res 58: 167–174PubMedCrossRefGoogle Scholar
  110. 110.
    Sacchetti B, Ambrogi Lorenzini C, Baldi E, Tassoni G, Bucherelli C (1999) Auditory thalamus, dorsal hippocampus, basolateral amygdala, and perirhinal cortex role in the consolidation of conditioned freezing to context and to acoustic conditioned stimulus in the rat. J Neurosci 19: 9570–9578PubMedGoogle Scholar
  111. 111.
    Power AE (2004) Muscarinic cholinergic contribution to memory consolidation: with attention to involvement of the basolateral amygdala. Curr Med Chem 11: 987–986PubMedCrossRefGoogle Scholar
  112. 112.
    Vazdarjanova A, McGaugh JL (1999) Basolateral amygdala is involved in modulating consolidation of memory for classical conditioning. J Neurosci 19: 6615–6622PubMedGoogle Scholar
  113. 113.
    Passani MB, Cangioli I, Baldi E, Bucherelli C, Mannaioni PF, Blandina P (2001) Histamine H3 receptor-mediated impairment of contextual fear conditioning, and in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala. Eur J Neurosci 14: 1522–1532PubMedCrossRefGoogle Scholar
  114. 114.
    Cangioli I, Baldi E, Mannaioni PF, Bucherelli C, Blandina P, Passani MB (2002) Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur J Neurosci 16: 521–528PubMedCrossRefGoogle Scholar
  115. 115.
    Anichtchik OV, Huotari M, Peitsaro N, Haycock JW, Männistö PT, Panula P (2000) Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci 12: 3823–3832PubMedCrossRefGoogle Scholar
  116. 116.
    Cenni G, Cangioli I, Yamatodani A, Passani MB, Mannaioni PF, DiFelice AM, Blandina P (2004) Thioperamide-elicited increase of histamine release from basolateral amygdala of freely moving rats and its therapeutic implications. Inflamm Res 53: S53–S54PubMedCrossRefGoogle Scholar
  117. 117.
    Alvarez E, Ruarte M (2002) Histaminergic neurons of the ventral hippocampus and the baso-lateral amygdala of the rat: functional interaction on memory and learning mechanisms. Behavioural Brain Research 128: 81–90PubMedCrossRefGoogle Scholar
  118. 118.
    Bacciottini L, Passani MB, Mannaioni PF, Blandina P (2001) Interactions between histaminergic and cholinergic systems in learning and memory. Beh Brain Res 124: 183–194CrossRefGoogle Scholar
  119. 119.
    Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274–285PubMedCrossRefGoogle Scholar
  120. 120.
    Giovannini M, Efoudebe M, Passani M, Baldi E, Bucherelli C, Giachi F, Corradetti R, Blandina P (2003) Improvement in fear memory by histamine elicited erk2 activation in hippocampal CA3 cells. J Neurosci 23: 9016–9023PubMedGoogle Scholar
  121. 121.
    Alves-Rodrigues A, Timmerman H, Willems E, Lemstra S, Zuiderveld OP, Leurs R (1998) Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus. Brain Res 788: 179–186PubMedCrossRefGoogle Scholar
  122. 122.
    Bacciottini L, Passani M, Giovannelli L, Cangioli I, Mannaioni P, Schunack W, Blandina P (2002) Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving animal. Eur J Neurosci 15: 1669–1680PubMedCrossRefGoogle Scholar
  123. 123.
    Schafe GE, Nader K, Blair HT, LeDoux JE (2001) Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. TINS 24: 540–546PubMedGoogle Scholar
  124. 124.
    Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD (1998) The MAPK cascade is required for mammalian associative learning. Nature Neurosci 1: 602–609PubMedCrossRefGoogle Scholar
  125. 125.
    Walz R, Lenz G, Roesler R, Vianna M, Martins V, Brentani R, Rodnight R, Izquierdo I (2000) Time-dependent enhancement of inhibitory avoidance retention and MAPK activation by post-training infusion of nerve growth factor into CA1 region of hippocampus of adult rats. Eur J Neurosci 12: 2185–2189PubMedCrossRefGoogle Scholar
  126. 126.
    Roozendaal B, Quirarte G, McGaugh J (2000) Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor-cAMP/cAMP/PKA system in influencing memory consolidation. Eur J Neurosci 15: 553–60CrossRefGoogle Scholar
  127. 127.
    Yanovsky Y, Haas HL (1998) Histamine increases the bursting activity of pyramidal cells in the CA3 region of mouse hippocampus. Neurosci Lett 240: 110–112PubMedCrossRefGoogle Scholar
  128. 128.
    Adams JP, Sweatt JD (2002) Molecular physiology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42: 135–163PubMedCrossRefGoogle Scholar
  129. 129.
    Smith CPS, Hunter AJ, Bennett GW (1994) Effects of (R)-a-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze. Psychopharmacology 114: 651–656PubMedCrossRefGoogle Scholar
  130. 130.
    Rubio S, Begega A, Santin L, Arias J (2002) Improvement of spatial memory by (R)-alpha-methylhistamine, a histamine H(3)-receptor agonist, on the Morris water-maze in rat. Behav Brain Res 129: 77–82PubMedCrossRefGoogle Scholar
  131. 131.
    Emery N, Amaral D (2000) The cognitive neuroscience of emotion. Oxford University Press, New YorkGoogle Scholar
  132. 132.
    Amaral D (2002) The primate amygdala and the neurobiology of social behavior: Implications for understanding social anxiety. Biological Psychiatry 51: 11–17PubMedCrossRefGoogle Scholar
  133. 133.
    Schneider F, Weiss U, Kessler C, Muller-Gartner HW, Posse S, Salloum JB, Grodd W, Himmelmann F, Gaebel W, Birbaumer N (1999) Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 45: 863–871PubMedCrossRefGoogle Scholar
  134. 134.
    Kelly JS (1999) Alzheimer’s disease: the tacrine legacy. Trends Pharmacol Sci 20: 127–129PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2006

Authors and Affiliations

  • Patrizio Blandina
    • 1
  • Maria Beatrice Passani
    • 1
  1. 1.Dipartimento di Farmacologia Preclinica e ClinicaUniversità di FirenzeItaly

Personalised recommendations